See also our related blog for the Pediatric Preclinical Testing Initiative.

Monday, October 20, 2014

exciting news

How much is a tumor like a wound?  Will tumor cells interact with the body's normal muscle stem cells, co-opting them for advantage to the tumor?  Can IL-4 Receptor antibodies block this process? These are the questions in our NIH R01 grant application that was scored this week in the top 4% of grants for that review cycle (usually, the top 9% of grants are funded).  We're very excited about this grant, and the probable 5 years of funding to pursue these question that we think will benefit patients with rhabdomyosarcoma in a tangible way.  Kudos to Megan, who took strong work by Imran, Tohru and GH to the next level and made this project possible.